Literature DB >> 8462979

Changes of telomere lengths in human intracranial tumours.

P Nürnberg1, G Thiel, F Weber, J T Epplen.   

Abstract

The termini of human chromosomes comprise stretches of G-rich repeats that are about 5-20 kilobase (kb) in length. The size of the telomeres can be determined by hybridization with probes specific for these (ttaggg)n sequences after digestion of chromosomal DNA with appropriate restriction enzymes and electrophoretic separation of the fragments. Here, probing with the 32P-labelled synthetic (TTAGGG)3 oligonucleotide revealed length changes of the telomeres occurring in intracranial tumours. Among 60 samples, analysed, 41.7% showed telomere elongation, and 21.7% telomere reduction, whereas 36.7% of the tumours exhibited equal lengths compared with the patients' peripheral blood leukocytes. Most of the elongated glioma telomeres exceeded in length those of untransformed astrocytes derived from human fetal tissue.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8462979     DOI: 10.1007/bf00222724

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  13 in total

Review 1.  Structure and function of telomeres.

Authors:  E H Blackburn
Journal:  Nature       Date:  1991-04-18       Impact factor: 49.962

Review 2.  Beginning or end? Telomere structure, genetics and biology.

Authors:  D Kipling; H J Cooke
Journal:  Hum Mol Genet       Date:  1992-04       Impact factor: 6.150

3.  The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats.

Authors:  G B Morin
Journal:  Cell       Date:  1989-11-03       Impact factor: 41.582

4.  A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes.

Authors:  R K Moyzis; J M Buckingham; L S Cram; M Dani; L L Deaven; M D Jones; J Meyne; R L Ratliff; J R Wu
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

5.  Coamplification of simple repetitive DNA fingerprint fragments and the EGFR gene in human gliomas.

Authors:  P Nürnberg; H Zischler; E Fuhrmann; G Thiel; T Losanova; D Kinzel; G Nisch; R Witkowski; J T Epplen
Journal:  Genes Chromosomes Cancer       Date:  1991-03       Impact factor: 5.006

6.  Hypervariable ultra-long telomeres in mice.

Authors:  D Kipling; H J Cooke
Journal:  Nature       Date:  1990-09-27       Impact factor: 49.962

7.  Detection of somatic changes in human renal cell carcinomas with oligonucleotide probes specific for simple repeat motifs.

Authors:  S Bock; J T Epplen; H Noll-Puchta; M Rotter; H Höfler; T Block; R Hartung; G Jakse; W Wilmanns; P E Petrides
Journal:  Genes Chromosomes Cancer       Date:  1993-02       Impact factor: 5.006

8.  Telomeres shorten during ageing of human fibroblasts.

Authors:  C B Harley; A B Futcher; C W Greider
Journal:  Nature       Date:  1990-05-31       Impact factor: 49.962

9.  Astrocyte cultures from human embryonic brain: characterization and modulation of surface molecules by inflammatory cytokines.

Authors:  F Aloisi; G Borsellino; P Samoggia; U Testa; C Chelucci; G Russo; C Peschle; G Levi
Journal:  J Neurosci Res       Date:  1992-08       Impact factor: 4.164

10.  Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity.

Authors:  C M Counter; A A Avilion; C E LeFeuvre; N G Stewart; C W Greider; C B Harley; S Bacchetti
Journal:  EMBO J       Date:  1992-05       Impact factor: 11.598

View more
  9 in total

1.  The telomerase inhibitor PinX1 is a major haploinsufficient tumor suppressor essential for chromosome stability in mice.

Authors:  Xiao Zhen Zhou; Pengyu Huang; Rong Shi; Tae Ho Lee; Gina Lu; Zhihong Zhang; Roderick Bronson; Kun Ping Lu
Journal:  J Clin Invest       Date:  2011-03-23       Impact factor: 14.808

2.  Telomerase activity in skeletal sarcomas.

Authors:  G Aue; B Muralidhar; H S Schwartz; M G Butler
Journal:  Ann Surg Oncol       Date:  1998 Oct-Nov       Impact factor: 5.344

3.  Telomerase activity in human ovarian carcinoma.

Authors:  C M Counter; H W Hirte; S Bacchetti; C B Harley
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

Review 4.  Genetics of primary brain tumors: a review.

Authors:  M Bondy; J Wiencke; M Wrensch; A P Kyritsis
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

5.  Telomere reduction in giant cell tumor of bone and with aging.

Authors:  H S Schwartz; G A Dahir; M G Butler
Journal:  Cancer Genet Cytogenet       Date:  1993-12

6.  Cytogenetic, telomere, and telomerase studies in five surgically managed lumbosacral chordomas.

Authors:  M G Butler; G A Dahir; L K Hedges; S F Juliao; M F Sciadini; H S Schwartz
Journal:  Cancer Genet Cytogenet       Date:  1995-11

7.  PinX1: a sought-after major tumor suppressor at human chromosome 8p23.

Authors:  Xiao Zhen Zhou
Journal:  Oncotarget       Date:  2011-10

8.  Potential clinical role of telomere length in human glioblastoma.

Authors:  D La Torre; M Aguennouz; A Conti; M Giusa; G Raffa; R V Abbritti; A Germano'; F F Angileri
Journal:  Transl Med UniSa       Date:  2011-10-17

9.  Malignant transformation potentials of human umbilical cord mesenchymal stem cells both spontaneously and via 3-methycholanthrene induction.

Authors:  Qiuling Tang; Qiurong Chen; Xiulan Lai; Sizheng Liu; Yezeng Chen; Zexin Zheng; Qingdong Xie; Martin Maldonado; Zhiwei Cai; Shan Qin; Guyu Ho; Lian Ma
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.